Mendel is proud to announce its AI-driven Hallucination Detection research led by University of Massachusetts Amherst | Research with its paper accepted to the prestigious AI conference - ACM SIGKDD & Annual KDD Conference. As AI continues to integrate into healthcare, addressing hallucinations in LLM outputs will be vital. Our research developed a robust framework to automatically detect and categorize hallucinations into five types. The research tested OpenAI's GPT-4o and Meta's Llama-3 in a pilot study of 100 summaries. Furthermore, our product Hypercube was used as an option to review the summaries, detect hallucinations, and recommend changes to improve the accuracy. Thank you to our authors: Prathiksha Rumale Vishwanath, Simran Tiwari, Tejas Ganesh Naik, Sahil Gupta, Dung Thai, Wenlong Zhao, Sunjae Kwon, Victor Ardulov, Karim Tarabishy, Andrew McCallum, and Wael Salloum, Ph.D. For more information, please see our press release here: https://lnkd.in/gthYWx5b To try Hypercube, sign-up here: https://www.mendel.ai/#CTA
Mendel.ai
Software Development
San Jose, California 13,737 followers
Supercharge your clinical data workflows
About us
Mendel AI is the only clinical AI platform that performs clinical reasoning to supercharge clinical data workflows. Powered by coupling large language models with a clinical Hypergraph, Mendel's AI copilots, known as Hypercubes, offer clinically trustworthy and explainable insights, streamlining tasks like cohort building, chart review, and data discovery. Mendel's solutions cater to biopharma, providers, and diagnostics, integrating seamlessly with existing tools and delivering proven results We strive for excellency, to be authentic and original, and to make a difference by greeting our challenges head on. Please visit our website, mendel.ai, to learn more about our company, goals, and values.
- Website
-
https://mendel.ai/
External link for Mendel.ai
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- San Jose, California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Artificial Intelligence in Medicine, Treatment Recommendations, Cancer Treatments, Healthcare, Clinical Trials, Oncology, Healthtech, Machine Learning, NLP, OCR, Pharmacovigilance, Feasibility Study, Site Activation, Cohort Identification, Real World Evidence, Real World Data, Patientless Trials, Virtual Control Arm, AI, generative AI, and life sciences
Locations
-
Primary
111 W Saint John St
Suite 950
San Jose, California 95113, US
Employees at Mendel.ai
Updates
-
Why does AI in healthcare end of being so expensive and difficult to scale? HealthLeaders published a story that highlights a core symptom and cause of the challenges AI faces in healthcare when it comes to cost and scalability, tied to a challenge we’re very focused on at Mendel—AI hallucinations. “It’s actually really difficult to respond to these hallucinations by modifying the algorithm,” said @Ravi B. Parikh of Emory University. “You might be able to fine-tune and sort of say ‘Hey, we want to avoid this type of output’ and there's certain reward-based mechanisms to do that, but usually that's not in the health system’s control. Usually it's a developer who's having to respond to feedback that they're getting from the health system and then doing some things behind the hood that we don't honestly know about.” At Mendel, we’ve been focused on AI that is specifically built for clinical complexity, eliminating hallucinations and opening up opportunities to scale and respond in the ways physicians, like Dr. Parikh, require. You can read the full article authored by Eric Wicklund here: https://lnkd.in/eHgqT_k5
-
We are excited to announce our partnership with AWS. Our Hypercube Platform is now powered by AWS and available on the AWS Marketplace. AWS' commitment to supporting generative AI startups has been impressive, and we look forward to accelerating our partnership to transform generative AI for life sciences. Big shoutout to our AWS partner team and many supporters: Sydney Falk Chad Coder Yin He Tina Sayadi Sherry Karamdashti Jared Saul, MD Amit S. Matt Pearson Praveen Haridas Damon Cronkey Bret Borota, FACHE George Softas Caleb Wilkinson Christine C. Link to press release: https://lnkd.in/gmS3C2ax
-
Professor Mark Braunstein, a leader in health informatics, published a blogpost on AI for Clinical Trials. He features Mendel AI's neuro-symbolic technology for automatic cohort retrieval (ACR) as an approach for clinical trial matching. ACR authors: Dung Thai Victor Ardulov Jose Mena Simran Tiwari Gleb Erofeev, MCS Ramy Eskander, Ph.D. Karim Tarabishy Ravi B. Parikh Wael Salloum, Ph.D.
Last time we looked at a patient facing use case for AI. This time we are focused on its potential application in identifying patients for clinical trials. Mendel.ai #Mendel.AI
-
Join us on September 24th at 10 AM PT for an exclusive webinar on Supercharging Clinical Data Workflows with Mendel.ai and Snowflake! Register now to secure your spot! https://lnkd.in/eYcQChPt #AIinHealthcare, #ClinicalData, #MendelAI, #Snowflake, #Webinar, #HealthcareInnovation, #ClinicalReasoning, #HealthcareAI
Supercharging Clinical Data Workflows with Mendel AI and Snowflake
snowflake.com
-
Mendel is proud to announce its partnership with Snowflake. Mendel's product Hypercube is now Generally Available as a native app on Snowflake's AI Data Cloud. The collaboration enable customers to deploy Hypercube in their Snowflake environment and limit data egress. Join us on September 24th at 10 AM PT to understand the science and tech behind this story. We will discuss LLMs, use cases and most importantly the privacy guardrails that powers this! Watch a short clip to learn more about our partnership. Sign-up for Webinar: https://lnkd.in/gWDhgtiV Full Press Release: https://lnkd.in/gbKYxtYy Thank you to the Snowflake team for making this happen! Lisa Arbogast Harini Gopalakrishnan Eric Johanson Kevin Davis Kendyl Stewart Chanel Piper Carter Faust Preeti Grewal Harsha Kapre Kent Diep #llm #lifesciences #rwe #rwd #clinical #ai
-
In the September Edition Journal of AMIA (American Medical Informatics Association), an article was published on AI for clinical trials. Mendel was highlighted as one of two companies, along with IBM watsonx, and the article highlighted Mendel's transformation of clinical trials: "For instance, in an ongoing oncology trial, the utilization of Mendel.ai led to a 24%-50% increase in the number of patients accurately identified as potentially eligible compared to the standard practice. Furthermore, using Mendel.ai to determine potential eligibility only takes minutes, while it takes an average of 19 days for standard prescreening of breast cancer patients and 263 days for lung cancer patients." Try our product today: https://lnkd.in/gxMa-Tws Read the full article here: https://lnkd.in/gXXgAzmQ
Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review
academic.oup.com
-
How are diagnostics and drug companies turning the elimination of AI hallucinations into more proactive, affordable and equitable systems of care? Come see Jose Mena and Michael Longo at BioTechX 2024 in Philadelphia! Ask our team about supercharging clinical data workflows and turning a flywheel for health assurance. Book time to meet with our team here: https://lnkd.in/g4WVAfhW #BIOTECHX2024 #HealthcareAI
-
Webinar Announcement! Join us on September 24th for an exclusive webinar on Supercharging Clinical Data Workflows with Mendel.ai I and Snowflake! Discover how cutting-edge AI and cloud technologies are transforming the way clinical data is managed, analyzed, and utilized to drive better outcomes. Whether you're in #healthcare, #LifeSciences, or #ClinicalResearch, this session will give you the insights and tools you need to streamline your data workflows and unlock new efficiencies. Don't miss out—register now to secure your spot! https://lnkd.in/eYcQChPt #AIinHealthcare #ClinicalData #MendelAI #Snowflake #Webinar #HealthcareInnovation #ClinicalReasoning #HealthcareAI